Advertisement
Video

Bincy Abraham, MD, on Positioning Biosimilars in the Management of IBD

09/26/2020

Bincy Abraham, MD, reviews her presentation on positioning biosimilars as first-line or switch therapies for patients with IBD, which she presented at the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting on September 26. 

Additional Resources:

 

AIBD newsroom

For more information about AIBD 2020 and to register for the AIBD Annual Meeting in December, visit https://www.advancesinibd.com

Bincy Abraham, MD, is director of the Fondren Inflammatory Bowel Disease Program at Houston Methodist Hospital in Houston, Texas.

 

 

Related Content

Cardiometabolic Risk
Donna H. Ryan, MD
Cardiometabolic Risk
CRS 2014: Principles of Obesity: Old Ways of Thinking, Same Old Results
10/11/2014
2014 Summit Faculty Donna H. Ryan, MD, discusses her presentation on the principles of obesity and how the old ways of thinking influence lackluster results for your patients.
10/11/2014
Inflammatory Bowel Disease
Edward Barnes
Inflammatory Bowel Disease
Edward Barnes, MD, on Management of Pouch Complications
09/12/2020
Edward Barnes, MD, from the University of North Carolina at Chapel Hill, discusses the presentation he made at the September 12 virtual regional meeting of Advances in Inflammatory Bowel Disease on managing...
09/12/2020
Anticoagulation
Michael Bloch, MD
Anticoagulation
Michael J. Bloch, MD, on a Preview of the Anticoagulation Sessions at CHEST 2021
10/14/2015
In this video, Michael J. Bloch, MD, provides a preview of the virtual anticoagulation sessions at CHEST 2021, including an update on COVID-19 and venous thromboembolic disease challenges and clinical trial...
10/14/2015
Nutrition
Timothy Harlan
Nutrition
Timothy Harlan, MD, on the Mediterranean Diet for Heart Health
05/12/2021
Timothy Harlan, MD, gives a preview of his session at our Practical Updates in Primary Care 2021 Virtual Series on May 13, in which he will discuss practical uses for the mediterranean diet based on new...
05/12/2021
Inflammatory Bowel Disease
Bruce Sands, MD
Inflammatory Bowel Disease
Bruce Sands, MD, MS, on When to Recommend a JAK Inhibitor for IBD
06/25/2019
In this video, Bruce Sands, MD, MS, from the Icahn School of Medicine at Mount Sinai, discusses when a gastroenterologist should recommend a JAK inhibitor for the treatment of ulcerative colitis.
06/25/2019